Dr. Brother's works on small molecule drug discovery and development for a variety of diseases. This is inclusive of target identification, small molecule drug screening, lead compound development, preclinical disease models, drug development and even some clinical development. His research also encompasses projects on repurposing known FDA approved drugs and programs to identify personalized medicine solutions for cancer patients who have exhausted all other treatment options.